乙烯基氯_MSDS_用途_密度_乙烯基氯CAS号【75-01-4】

【用途一】
用作多种聚合物的共聚单体
【用途二】
塑料工业的重要原料，主要用于生产聚氯乙烯树脂。与醋酸乙烯、偏氯乙烯、丁二烯、丙烯腈、丙烯酸酯类及其他单体共聚生成共聚物，也可用作冷冻剂等。

[ 密度 ]:
0.911 g/mL at 25 °C(lit.)

[ 沸点 ]:
-10 ºC

[ 熔点 ]:
-153.8 °C(lit.)

[ 分子式 ]:
C₂H₃Cl

[ 分子量 ]:
62.49820

[ 闪点 ]:
-56 ºC

[ 精确质量 ]:
61.99230

[ LogP ]:
1.36870

[ 外观性状 ]:
无色气体

[ 折射率 ]:
n20/D 1.3700(lit.)

[ 储存条件 ]:
库房通风低温干燥,轻装轻卸,与氧气、空气等助燃气体钢瓶分开存放

[ 水溶解性 ]:
acetone/carbon disulfide, MEK, THF: soluble

CHEMICAL IDENTIFICATION

RTECS NUMBER :: KU9625000

CHEMICAL NAME :: Ethylene, chloro-

CAS REGISTRY NUMBER :: 75-01-4

BEILSTEIN REFERENCE NO. :: 1731576

LAST UPDATED :: 199806

DATA ITEMS CITED :: 127

MOLECULAR FORMULA :: C2-H3-Cl

MOLECULAR WEIGHT :: 62.50

WISWESSER LINE NOTATION :: G1U1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 500 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: DOWCC* Dow Chemical Company Reports. (Dow Chemical USA, Health and Environment Research, Toxicology Research Lab., Midland, MI 48640)

TYPE OF TEST :: LC50 - Lethal concentration, 50 percent kill

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 18 pph/15M

TOXIC EFFECTS :: Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression

TYPE OF TEST :: LCLo - Lowest published lethal concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 20 pph/30M

TOXIC EFFECTS :: Behavioral - general anesthetic

TYPE OF TEST :: LCLo - Lowest published lethal concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 30 pph/30M

TOXIC EFFECTS :: Behavioral - general anesthetic

TYPE OF TEST :: LCLo - Lowest published lethal concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Mammal - species unspecified

DOSE/DURATION :: 200 ppm/18M

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 23400 mg/kg/13W-I

TOXIC EFFECTS :: Liver - changes in liver weight Blood - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 30 mg/m3/4H/26W-I

TOXIC EFFECTS :: Cardiac - arrhythmias (including changes in conduction) Cardiac - EKG changes not diagnostic of specified effects Cardiac - pulse rate

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 5000 ppm/7H/52W-I

TOXIC EFFECTS :: Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Endocrine - changes in spleen weight

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 400 mg/m3/24H/14W-C

TOXIC EFFECTS :: Behavioral - muscle contraction or spasticity Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Liver - changes in liver weight

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 28000 ppm/7H/6W-I

TOXIC EFFECTS :: Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other transferases

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 2000 ppm/8H/92D-I

TOXIC EFFECTS :: Liver - changes in liver weight Endocrine - changes in spleen weight Blood - changes in leukocyte (WBC) count

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 9 gm/m3/4H/22W-I

TOXIC EFFECTS :: Cardiac - arrhythmias (including changes in conduction) Cardiac - EKG changes not diagnostic of specified effects Cardiac - pulse rate

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 30 mg/m3/26W-I

TOXIC EFFECTS :: Brain and Coverings - recordings from specific areas of CNS Blood - other changes Musculoskeletal - osteoporosis

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Human - man

DOSE/DURATION :: 200 ppm/14Y-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 3463 mg/kg/52W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Kidney, Ureter, Bladder - Kidney tumors

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1 ppm/4H/52W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 10000 ppm/4H female 12-18 day(s) after conception

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Reproductive - Tumorigenic effects - transplacental tumorigenesis Endocrine - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 21 mg/kg/65W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors Gastrointestinal - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 21 mg/kg/67W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 50 ppm/30W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Vascular - tumors Skin and Appendages - tumors

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - hamster

DOSE/DURATION :: 50 ppm/4H/30W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Blood - lymphoma, including Hodgkin's disease Skin and Appendages - tumors

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 50 ppm/7H/26W-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Vascular - tumors Skin and Appendages - tumors

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 100 ppm/7H/26W-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Skin and Appendages - tumors

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 50 ppm/47W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Lungs, Thorax, or Respiration - tumors Liver - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 34 gm/kg/3Y-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - angiosarcoma Kidney, Ureter, Bladder - Kidney tumors

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 50 ppm/6H/4W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Lungs, Thorax, or Respiration - tumors Skin and Appendages - tumors

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 50 ppm/4H/30W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Skin and Appendages - tumors

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 250 ppm/2Y-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Sense Organs and Special Senses (Ear) - effect, not otherwise specified Liver - angiosarcoma

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Human

DOSE/DURATION :: 300 mg/m3/W-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Blood - tumors

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 5 ppm/4H/52W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :: TC - Toxic concentration (other than lowest)

ROUTE OF EXPOSURE :: Inhalation

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 50 ppm/6H/43W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 30 mg/m3

SEX/DURATION :: male 5 year(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 100 ppm/6H

SEX/DURATION :: male 26 week(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - testes, epididymis, sperm duct

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 500 ppm/7H

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 1500 ppm/24H

SEX/DURATION :: female 1-9 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 500 ppm/7H

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 250 ppm/6H

SEX/DURATION :: female 55 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Fertility - female fertility index (e.g. # females pregnant per # sperm positive females; # females pregnant per # females mated)

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 30000 ppm/6H

SEX/DURATION :: male 5 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 500 ppm/7H

SEX/DURATION :: female 6-15 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system

TYPE OF TEST :: TCLo - Lowest published toxic concentration

ROUTE OF EXPOSURE :: Inhalation

DOSE :: 500 ppm/7H

SEX/DURATION :: female 6-18 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Specific Developmental Abnormalities - musculoskeletal system

TYPE OF TEST :: Sex chromosome loss and nondisjunction

TYPE OF TEST :: Morphological transformation

TYPE OF TEST :: DNA adduct

TYPE OF TEST :: DNA damage

TYPE OF TEST :: DNA inhibition

TYPE OF TEST :: Cytogenetic analysis

TYPE OF TEST :: Micronucleus test

TYPE OF TEST :: Cytogenetic analysis

TYPE OF TEST :: Cytogenetic analysis

TYPE OF TEST :: Sister chromatid exchange

MUTATION DATA

TYPE OF TEST :: Mutation in mammalian somatic cells

TEST SYSTEM :: Rodent - hamster Ovary

REFERENCE :: EVSRBT Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- Volume(issue)/page/year: 25,91,1982 *** REVIEWS *** ACGIH TLV-Confirmed human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 13 mg/m3 (5 ppm) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Human Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 19,377,1979 IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 19,377,1979 IARC Cancer Review:Group 1 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,373,1987 TOXICOLOGY REVIEW FAZMAE Fortschritte der Arzneimittelforschung. Progress in Drug Research. (Birkhauser Boston, Inc., c/o Springer-Verlag New York, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1959- Volume(issue)/page/year: 18,365,1974 TOXICOLOGY REVIEW JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- Volume(issue)/page/year: 1,47,1975 TOXICOLOGY REVIEW CMTVAS Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- Volume(issue)/page/year: 10(3),49,1973 TOXICOLOGY REVIEW CHWEAP Chemisch-Weekblad. (The Hague, Netherlands) V.1-71, 1903-75. Volume(issue)/page/year: 70(28/29),5,1974 TOXICOLOGY REVIEW CANCAR Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- Volume(issue)/page/year: 39,1792,1977 TOXICOLOGY REVIEW MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 32,93,1975 TOXICOLOGY REVIEW ZHPMAT Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. Volume(issue)/page/year: 166,113,1978 TOXICOLOGY REVIEW BNYMAM Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- Volume(issue)/page/year: 54,413,1978 TOXICOLOGY REVIEW ABMHAM Archives Belges de Medecine Sociale, Hygiene, Medecine du Trevail et Medecine Legale. (Quartier Esplanade no.6, 1010 Brussels, Belgium) V.4- 1946- Volume(issue)/page/year: 35,585,1977 TOXICOLOGY REVIEW CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year: 22,117,1978 TOXICOLOGY REVIEW GTPZAB Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI Volume(issue)/page/year: 20(4),46,1976 TOXICOLOGY REVIEW VHTODE Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- Volume(issue)/page/year: 22,31,1980 TOXICOLOGY REVIEW MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 41,131,1976 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 200 ppm (510 mg/m3) DTLWS* "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. Volume(issue)/page/year: 3,31,1973 OSHA PEL (Construc):see CFR 29,1926.1117 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Fed Cont):8H TWA 500 ppm (13 mg/m3) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 OSHA-cancer suspect agent CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1017,1987 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-ARAB Republic of Egypt:TWA 2.5 mg/m3 JAN 1993 OEL-AUSTRALIA:TWA 5 ppm (10 mg/m3);Carcinogen JAN 1993 OEL-BELGIUM:TWA 5 ppm (13 mg/m3);Carcinogen JAN 1993 OEL-DENMARK:TWA 1 ppm (3 mg/m3);Carcinogen JAN 1993 OEL-FINLAND:TWA 5 ppm (15 mg/m3);STEL 10 ppm (30 mg/m3);Carcinogen JAN 1993 OEL-FRANCE:TWA 1 ppm (3 mg/m3);Carcinogen JAN 1993 OEL-GERMANY;Carcinogen JAN 1993 OEL-HUNGARY:STEL 10 mg/m3;Carcinogen JAN 1993 OEL-JAPAN:STEL 2.5 ppm;Carcinogen JAN 1993 OEL-THE NETHERLANDS JAN 1993 OEL-THE PHILIPPINES:TWA 50 ppm (100 mg/m3) JAN 1993 OEL-POLAND:TWA 30 mg/m3 JAN 1993 OEL-RUSSIA:TWA 1 mg/m3;STEL 2.5 ppm (5 mg/m3) JAN 1993 OEL-SWEDEN:TWA 1 ppm (2.5 mg/m3);STEL 5 ppm (13 mg/m3);Skin;Carcinogen JAN 1993 OEL-SWITZERLAND:TWA 2 ppm (5.2 mg/m3);Carcinogen JAN 1993 OEL-THAILAND:TWA 1 ppm (2.8 mg/m3) JAN 1993 OEL-TURKEY:TWA 500 ppm (1300 mg/m3) JAN 1993 OEL-UNITED KINGDOM:TWA 7 mg/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO VINYL CHLORIDE-air:CA lowest feasible concentration REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 76445 No. of Facilities: 1459 (estimated) No. of Industries: 22 No. of Occupations: 36 No. of Employees: 29836 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 76445 No. of Facilities: 3711 (estimated) No. of Industries: 63 No. of Occupations: 59 No. of Employees: 81314 (estimated) No. of Female Employees: 28398 (estimated)

[ 符号 ]:

GHS02, GHS06, GHS08

[ 信号词 ]:
Danger

[ 危害声明 ]:
H225-H301 + H311 + H331-H350-H370

[ 警示性声明 ]:
P201-P210-P260-P280-P301 + P310-P311

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ 危害码 (欧洲) ]:
F+,T,F

[ 风险声明 (欧洲) ]:
R45

[ 安全声明 (欧洲) ]:
S53-S45-S36/37

[ 危险品运输编码 ]:
UN 1086 2.1

[ WGK德国 ]:
2

[ RTECS号 ]:
KU9625000

[ 危险类别 ]:
2.1

[ 海关编码 ]:
2903210000

乙烯基氯上游产品

乙烯基氯下游产品

1、乙烯氧氯化法，乙烯与氯气在三氯化铁催化剂存在下，液相直接氯化生成1,2-二氯乙烷。1,2-二氯乙烷经精制后裂解，得氯乙烯和氯化氢，经精馏得到成品氯乙烯。副产氯化氢、乙烯与空气，通过载于氧化铝上的氯化铜触媒进行氧氯化反应得1,2-二氯乙烷，精制后在500℃、2.0-2.5MPa压力下，在管式炉内裂解生成氯乙烯和氯化氢，精制得产品氯乙烯。副产品氯化氢可再返回氧氯化反应器与乙烯再进行氧氯化反应此法乙烯直接氯化转化率为99.7%，二氯乙烷选择为99%；二氯乙烷转化率为57%，氯乙烯选择性为99%。每吨产品消耗定额：乙烯（100%计）485kg，氯气（100%）630kg，蒸汽（1.11MPa）1900kg，煤气90.15-0.20MPa）5.235×1000000KJ，电10000V±6%，50Hz±5%，8.64×100000KW/t。 2、乙烯直接氯化法包括乙烯高温氯化和乙烯低温氯化等。
(1)乙烯低温氯化法先向乙烯通氯，在三氯化铁存在下制取二氯乙烷，在碱的醇溶剂中，二氯乙烷再脱氯化氢制取氯乙烯，其反应如下：二氯乙烷裂解要在600℃以上进行。它除了脱第一个氯化氢生产氯乙烯外，还发生脱第二个氯化氢反应而生成乙炔，因而使氯乙烯产率降低。为了提高产率，必须使用催化剂，如活性炭、硅胶等，这样反应可以温度480-520℃下进行，氯乙烯产率可达85%。
(2)乙烯高温氯化法以乙烯、氯气为原料，经高温氯化生产氯乙烯，同时副产多种氯代烃溶剂。整个工艺过程分热氯化、冷氯化和氧氯化三部分。其过程如下。
热氯化：乙烯、氯气和循环的二氯乙烷、三氯乙烷在热压反应釜内，于0.15MPa压力、374-495℃温度条件下反应，不用催化剂，生成氯乙烯经分离、精制而得产品，其佘二氯乙烷和三氯乙烷返回热压釜；氯化氢和未反应的乙烯送氧氯化工序。
冷氯化：使热氯化工序来的二氯乙烯与氯气反应成四氯乙烷，或与氯化氢反应得1，1，1-三氯乙烷，反应也不需要催化剂。所得四氯乙烷经热裂解而得三氯乙烯，氯化氢则送氧氯化工序。
氧氯化：以铜盐为催化剂，在0.2-0.78MPa、222-476℃温度下反应生成二氯乙烷、三氯乙烷、四氯乙烷和水，经分离得三氯乙烷、二氯乙烷产品，其佘氯代烃返回热氯化系统。
3、烯炔法此法有两种。
(1)联合法以乙烯、乙炔为原料，经氯化后，其中乙烯生成二氯乙烷；二氯乙烷裂解制氯乙烯，所副产的氯化氢与乙炔进行加成反应得氢乙烯，这样就可避免副产氯化氢。
该法采用的原料一半来自电石乙炔，一半来自石油乙烯。因此采用电石法生产氯乙烯的工厂，转向石油路线时，用此法作为过渡阶段比较简便，可以利用原有设备。
在国内采用重油为原料，经蓄热炉裂解，制成含乙烯25%-30%的混合气，再简易分离去除C3以上组分，制得的稀乙烯，与氯气在35-40℃、三氯化铁存在下，合成二氯乙烷。粗二氯乙烷经闪蒸精制，在管式炉内。其中副产氯化氢送往电石法氯乙烯工序合成氯乙烯。氯乙烯质量可达到聚合要求。
(2)混合烯炔法以石脑油为原料，经2000℃的温度进行火焰裂解制得乙炔、乙烯混合气，在除去C3以上馏分和焦炭等杂质后，不经分离直接与氯化氢混合，在氯化汞催化剂存在下，乙炔与氯化氢反应生成氯乙烯，分离氯乙烯后的混合气体，通氯气与乙烯合成二氯乙烷；二氯乙烷再经热裂解得氯乙烯和氯化氢，氯化氢经提纯干燥后，送回，与混合气中的乙炔反应，用于合成氯乙烯。
裂解条件：炉温2000℃，常压，烯炔比1.2：1，烯烃产率48%-53%。氯乙烯产率：以乙炔计为95%-98%，以氯气计为99%，以乙烯计为95%-985；二氯乙烷转化率为50%，氯乙烯收率为96%。
4、电石乙炔法以电石为原料制乙炔，在以活性炭为载体氯化汞催化剂存在下，与氯化加成而得。
配料摩尔比为：乙炔：氯化氢=1：（1.08-1.1）。乙炔和氯化氢按上述配比混合物后进行列管装有催化剂，借列管外的循环冷却水带走。反应气体中还含有未反应的氯化氢、乙炔和生成的乙醛、1，1-二氯乙烷及顺二氯乙烯、反二氯乙烯等化合物。反应后的粗氯乙烯气体，经水洗塔、碱洗塔，洗去气体中氯化氢及二氧化碳。碱洗后气体，通过干燥塔进行压缩全凝、液化，液体氯乙烯分别送入低沸点塔及高沸点塔，去除高、低沸点物即得聚合级氯乙烯单体。消耗定额（kg/t）：乙炔429，氯化氢680，氯化汞2。

[ 海关编码 ]: 2903210000

Catalysis: The accelerator.

Nature 495(7440) , S10-1, (2013)

Biodegradable surfactant stabilized nanoscale zero-valent iron for in situ treatment of vinyl chloride and 1,2-dichloroethane.

J. Hazard. Mater. 211-212 , 373-80, (2012)

Nanoscale zero-valent iron (NZVI) stabilized with dispersants is a promising technology for the remediation of contaminated groundwater. In this study, we demonstrated the use of biodegradable surfact...

Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene.

Chemosphere 31(1) , 2561-78, (1995)

Risk assessments for vinyl chloride (VC) and trichloroethylene (TCE) are presented as examples of approaches for incorporating chemical-specific pharmacokinetic and mechanistic information into a more...

更多文献